STOCK TITAN
  1. Home
  2. News
  3. ZOM

Zomedica Corp. - $ZOM STOCK NEWS

Welcome to our dedicated page for Zomedica news (Ticker: $ZOM), a resource for investors and traders seeking the latest updates and insights on Zomedica stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zomedica's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zomedica's position in the market.

News
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses
Rhea-AI Summary
Zomedica Corp. announces commercial launch of eACTH assay for equine plasma on TRUFORMA platform, targeting equine veterinarians. Assay enables diagnosis of equine Cushing's Disease and monitoring of positive patients. Business opportunity to engage with Equine Veterinary community and reach millions of horses in the US susceptible to PPID.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.49%
Tags
none
-
News
Zomedica Provides Corporate Update
Rhea-AI Summary
Zomedica Corp. has received a notice from NYSE American stating that it is not in compliance with the listing standards due to low share price. The company plans to take measures to cure the deficiency and remain listed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.49%
Tags
none
-
News
Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio
Rhea-AI Summary
Zomedica Corp. completes acquisition of Structured Monitoring Products, Inc. and plans to manufacture and distribute VetGuardian touchless vital signs monitoring technology
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
acquisition
News
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Rhea-AI Summary
Zomedica Corp. CEO to provide strategic update at H.C. Wainwright conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News
Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity
Rhea-AI Summary
Zomedica Corp. reports Q2 2023 financial results, with revenue of $6.0 million, a 43% increase compared to Q2 2022. Therapeutic segment revenue increased by 38% and diagnostic segment revenue doubled. Gross margin was 67%. Zomedica ended the quarter with $142.4 million in cash. The company expects revenue to continue increasing in subsequent periods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
earnings
-
News
Zomedica to Present at Sidoti Virtual Investor Conference August 16-17
Rhea-AI Summary
Zomedica Corp. (ZOM) CEO Larry Heaton to present at Sidoti August Virtual Investor Conference, offering point-of-care diagnostics and therapeutic products for companion animals. Investors can register for free to attend the live presentation and one-on-one meetings on August 16-17, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
conferences
News
Zomedica to Host Second Quarter Financial Results Call on August 10
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.43%
Tags
conferences earnings
-
News
Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services
Rhea-AI Summary
Zomedica Corp. has announced the launch of the TRUVIEW digital microscopy platform, featuring the TRUprep system and LiquiView liquid lens technology. The all-in-one TRUVIEW system combines advanced optics, automated slide preparation, and tele-pathology to improve veterinarian diagnostic confidence. The TRUprep system eliminates the need for manual slide preparation, saving technician time and improving workflow. The digital imaging and telepathology component allows veterinarians to review slides digitally or send them for external review. Zomedica will initially offer the TRUVIEW system to practices participating in its Customer Appreciation Program. The TRUVIEW microscope enhances diagnostic capabilities and streamlines workflow.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
-
News
Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
News
Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
Rhea-AI Summary
Zomedica Corp. reports Q1 2023 financial results with revenue of $5.5 million, a 45% increase compared to Q1 2022. Gross margin was 70%. The company ended Q1 with $147.5 million in cash. Zomedica plans to introduce new product platforms in 2023 and evaluate strategic business opportunities in the animal health sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.98%
Tags
earnings
Stock ZOM logo
Zomedica Corp.

NYSE:ZOM

ZOM Rankings

#3980 Ranked by Market Cap
#3990 Ranked by Stock Gains
N/A Ranked by Dividends

ZOM Stock Data

155.71M
963.34M
1.59%
8.89%
6.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ANN ARBOR

About ZOM

zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.